New treatments for systemic lupus erythematosus
New therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develo...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=Lahita |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841561360007168000 |
---|---|
author | Robert George Lahita |
author_facet | Robert George Lahita |
author_sort | Robert George Lahita |
collection | DOAJ |
description | New therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develop biological treatments for the disease using three approaches: B cell modulation, T cell regulation and cytokine inhibition. This paper reviews the current state of these three critical areas. |
format | Article |
id | doaj-art-c7ef360152734f6d93bf77f4e7b709ea |
institution | Kabale University |
issn | 0973-3698 0973-3701 |
language | English |
publishDate | 2017-01-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Indian Journal of Rheumatology |
spelling | doaj-art-c7ef360152734f6d93bf77f4e7b709ea2025-01-03T01:45:40ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012017-01-01121485110.4103/injr.injr_1_17New treatments for systemic lupus erythematosusRobert George LahitaNew therapies for systemic lupus erythematosus are rare. This is because of the complexity of the disease and its varied presentations. There are many variables and a variety of measurement scales that must be satisfied before a new agent is approved for use in humans. Attempts are ongoing to develop biological treatments for the disease using three approaches: B cell modulation, T cell regulation and cytokine inhibition. This paper reviews the current state of these three critical areas.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=LahitaB cellscytokine manipulationlupus treatmentsT cells |
spellingShingle | Robert George Lahita New treatments for systemic lupus erythematosus Indian Journal of Rheumatology B cells cytokine manipulation lupus treatments T cells |
title | New treatments for systemic lupus erythematosus |
title_full | New treatments for systemic lupus erythematosus |
title_fullStr | New treatments for systemic lupus erythematosus |
title_full_unstemmed | New treatments for systemic lupus erythematosus |
title_short | New treatments for systemic lupus erythematosus |
title_sort | new treatments for systemic lupus erythematosus |
topic | B cells cytokine manipulation lupus treatments T cells |
url | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=48;epage=51;aulast=Lahita |
work_keys_str_mv | AT robertgeorgelahita newtreatmentsforsystemiclupuserythematosus |